enGene Inc (ENGN)
enGene Reports Full Year 2025 Financial Results and Provides Business Update
Amneal Pharmaceuticals Inc. (AMRX)
Amneal Pharmaceuticals, Inc. - Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Celularity Inc. (CELUW)
Celularity Announces Closing of Financing Transactions
Forte Biosciences Inc. (FBRX)
Forte Biosciences Inc - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Celularity Inc. (CELU)
Celularity Announces Closing of Financing Transactions
BridgeBio Pharma (BBIO)
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Amneal Pharmaceuticals Inc. (AMRX)
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Vertex Pharmaceuticals (VRTX)
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
Smart for Life, Inc. (SMFL)
How I Learned to Advocate for Myself as a Woman in Engineering
Alvotech (ALVOW)
Alvotech’s Financial Calendar for 2026